These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Radioactive iodine diagnosis and radiotherapy of endocrine ophthalmopathy]. HORST W; SAUTTER H; ULLERICH K Dtsch Med Wochenschr; 1960 Apr; 85():794-8 concl. PubMed ID: 14403212 [No Abstract] [Full Text] [Related]
6. [ALTERATION OF ENDOCRINE OPHTHALMOPATHY BY PLANT EXTRACTS]. KEMPER F; PORTHEINE H Verh Dtsch Ges Inn Med; 1964; 70():941-4. PubMed ID: 14294337 [No Abstract] [Full Text] [Related]
7. [EXPERIENCES IN THE TREATMENT OF SO-CALLED ENDOCRINE OPHTHALMOPATHY FROM THE VIEWPOINT OF THE INTERNIST]. JOHN H; SCHNEIDER G Radiobiol Radiother (Berl); 1963; 4():347-52. PubMed ID: 14044515 [No Abstract] [Full Text] [Related]
9. [Results of radiotherapy in 104 cases with malignant endocrine ophthalmopathy (With a contribution to the problem of radioresection of the thyroid in endorine ophthalmopathy)]. HORST W; ULLERICH C Strahlentherapie; 1959; Suppl 43():151-63. PubMed ID: 14403209 [No Abstract] [Full Text] [Related]
10. [The relation of the endocrine exophthalmos to the pituitary-thyroid system]. SAUTTER H Dtsch Med Wochenschr; 1956 May; 81(20):761-6. PubMed ID: 13330458 [No Abstract] [Full Text] [Related]
13. [A CONTRIBUTION TO THE DIFFERENTIATION OF THE CLINICAL TYPES OF ENDOCRINE OPHTHALMOPATHY]. DRAEGER J; SCHNEIDER C Klin Monbl Augenheilkd; 1963 Aug; 143():104-16. PubMed ID: 14083275 [No Abstract] [Full Text] [Related]
14. [Electromyographic studies in endocrine ophthalmopathy]. PAPST W; ESSLEN E Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():154-8. PubMed ID: 14483766 [No Abstract] [Full Text] [Related]
15. [Measurement of ocular pressure, resistance to the flow of aqueous humor and rigidity in endocrine exophthalmias]. WEEKERS R; PRIJOT E; LAVERGNE G Ophthalmologica; 1960 May; 139():382-92. PubMed ID: 13843387 [No Abstract] [Full Text] [Related]
16. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy. Jankauskiene J; Imbrasiene D Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791 [TBL] [Abstract][Full Text] [Related]
17. PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA. PIMSTONE BL; HOFFENBERG R; BLACK E J Clin Endocrinol Metab; 1964 Oct; 24():976-82. PubMed ID: 14228536 [No Abstract] [Full Text] [Related]
18. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease. Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674 [TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities. Molnár I; Szentmiklósi JA; Somogyiné-Vári É Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432 [TBL] [Abstract][Full Text] [Related]